Should FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary?
Sykes, Andrew J
Carrington, Bernadette M
Julyan, Peter J
Homer, Jarrod J
Hastings, David L
Slevin, Nicholas J
AffiliationDepartment of Head & Neck Surgery, Christie Hospital, Manchester, UK. Pljs1@hotmail.com
MetadataShow full item record
AbstractBACKGROUND: Between 1 and 2 per cent of head and neck squamous cell carcinoma patients will reveal no evidence of a primary malignancy. The management of this group poses many problems, including the morbidity associated with wide field irradiation as well as the difficulty in treatment when a primary does emerge. The aim of this study was to assess the use of fluoro-deoxy-glucose positron emission tomography (FDG-PET) imaging in patients presenting with an unknown head and neck primary and to consider its routine use in such patients. METHODS: We enrolled 25 patients into our study over a four year period. They all presented with a histologically proven, metastatic, squamous cell carcinoma of the neck for which no primary could be found despite full clinical, endoscopic and radiological evaluation with computed tomography (CT) and/or magnetic resonance imaging (MRI). Additionally, all the patients underwent imaging using FDG-PET. The images were interpreted by two radiologists experienced in PET imaging. RESULTS: A primary was identified in nine of the 25 patients (42 per cent); however, of these patients, six had false positive results and only three patients were true positives with supportive histology. In the remaining 16 patients, no abnormality was identified on CT, MRI or PET. Of these 16 patients, two eventually displayed a primary carcinoma, the other 14 patients remaining without evidence of any primary. CONCLUSION: Despite the high number of positive PET scans, the actual true positive rate was 3/9 (33 per cent); conversely, the true negative rate was 14/16 (88 per cent). We conclude from this study that there is a role for FDG-PET in the patient with an unknown head and neck primary, particularly in the context of a negative PET scan.
CitationShould FDG-PET scanning be routinely used for patients with an unknown head and neck squamous primary? 2007, 121 (2):149-53 J Laryngol Otol
JournalThe Journal of Laryngology and Otology
- Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
- Authors: Nahmias C, Carlson ER, Duncan LD, Blodgett TM, Kennedy J, Long MJ, Carr C, Hubner KF, Townsend DW
- Issue date: 2007 Dec
- Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.
- Authors: Nayak JV, Walvekar RR, Andrade RS, Daamen N, Lai SY, Argiris A, Smith RP, Heron DE, Ferris RL, Johnson JT, Branstetter BF 4th
- Issue date: 2007 Dec
- Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer.
- Authors: Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, Kanegae K, Inubushi M, Tamaki N, Kitagawa Y
- Issue date: 2008 Apr
- Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
- Authors: Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Wiesser S, Heinisch M, Unterweger O, Raunik W, Kumnig G, Gomez I, Grünbacher G, Lind P
- Issue date: 2001 Jul
- Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
- Authors: Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, Yoshida M, Yonekura Y
- Issue date: 2003 Feb